MedPath

Roxavid

Brand Name: Roxavid

Generic Name: Rivaroxaban

Active
Registration Number

DRP-13728

Dosage Form

Film-Coated Tablet

Issuance Date

March 31, 2023

Expiry Date

March 31, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mg
PackagingAlu/Clear Transparent PVC-PVDC Blister Pack x 7's (Box of 28's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RivaroxabanActive
Monograph: Rivaroxaban

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform